Skip to main content
Person working at computer screen in dark room

Computer Vision Syndrome: The Two-Thirds Problem

If you spend hours staring at screens each day, you’re part of a global experiment in human vision. The results are in, and they’re not great: 69% of us now experience Computer Vision Syndrome (CVS).
What is CVS? Computer Vision Syndrome encompasses a range of eye and vision-related problems resulting from prolonged screen use, including eyestrain, headaches, dry eyes, and blurred vision.

The numbers are staggering

A comprehensive meta-analysis published in the Journal of Optometry in 2024 pooled data from 103 cross-sectional studies involving over 66,000 participants. The findings paint a clear picture of how widespread this problem has become.1

69%

Global prevalence of Computer Vision Syndrome

76%

Prevalence among university students

71%

Prevalence in women (vs 62% in men)

73%

Prevalence in contact lens wearers
These aren’t small differences. If you’re a female university student who wears contact lenses, you’re in one of the highest-risk groups for digital eye strain.

Three pathways to discomfort

Researchers have identified three distinct mechanisms through which screen use affects our visual system.2
Prolonged screen viewing often involves static postures that strain the neck, shoulders, and back. These symptoms frequently co-occur with visual discomfort, suggesting a connected system of strain.
Your eyes constantly adjust focus when reading on screens. Over time, this can lead to blurred vision, difficulty switching focus between distances, and even double vision. The closer the screen, the harder your eyes work.
This is perhaps the most common pathway. Reduced blinking, combined with air conditioning and low humidity environments, leads to tear film instability, causing redness, burning, and a gritty sensation.

The pandemic made it worse

During the COVID-19 pandemic, CVS prevalence reached as high as 94% in some populations as screen time skyrocketed for remote work and online education.2
The shift to remote work didn’t just increase screen time; it often degraded viewing conditions. Home setups rarely match the ergonomic standards of office environments, leading to:
  • Poor monitor positioning
  • Inadequate lighting
  • Longer uninterrupted work sessions
  • Less opportunity for visual breaks

Who’s most at risk?

The research consistently identifies several risk factors:
FactorImpact
Screen time greater than 3 hours daily90% of users report symptoms3
Contact lens wear73% vs 64% prevalence
Female genderHigher symptom reporting
Younger age (students)Highest prevalence group
Uncorrected vision problemsCompounds strain significantly

What you can do about it

The good news is that CVS is largely preventable and treatable. Evidence-based interventions include:
1

Optimize your environment

Position your screen 20-26 inches from your eyes, slightly below eye level. Ensure adequate, glare-free lighting.
2

Address dry eye

Consider a humidifier, use artificial tears, and make conscious efforts to blink fully and frequently.
3

Take strategic breaks

Research supports regular breaks, though the optimal protocol is still debated. More on this in our article on the 20-20-20 rule.
4

Get your vision checked

Uncorrected or under-corrected refractive errors significantly worsen CVS symptoms. A prescription optimized for your working distance can help.
EyeRhythm helps with this. By tracking your blink rate in real-time, you can catch the early signs of eye fatigue before symptoms become severe. Download EyeRhythm to start monitoring your eye health.

References

  1. Ccami-Bernal F, et al. (2024). Global prevalence of computer vision syndrome: A systematic review and meta-analysis. Journal of Optometry, 17(1):100482. DOI: 10.1016/j.optom.2023.100482. PMID: 37866176
  2. Kaur K, et al. (2022). Digital Eye Strain - A Comprehensive Review. Ophthalmology and Therapy, 11:1655-1680. DOI: 10.1007/s40123-022-00540-9. PMC: 9434525
  3. Blehm C, et al. (2005). Computer Vision Syndrome: A Review. Survey of Ophthalmology, 50(3):253-262. DOI: 10.1016/j.survophthal.2005.02.008. PMID: 15850814